Open-Label Access to ATH434 for Patients Who Completed Study ATH434-201 in France
Open-Label Access to ATH434 for Patients Who Completed Study ATH434-201 in France
Enrolling by invitation · NCT07729852 · Registry updated 2026-10-09Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Open-Label Access to ATH434 for Patients Who Completed Study ATH434-201 in France | autonomic nervous system disorder, basal ganglia disorder, brain disorder, central nervous system disorder, movement disorder, multiple system atrophy, nervous system disorder, neurodegenerative disease, primary dysautonomia, synucleinopathy | Enrolling by invitation | Phase 2 | 2026-10-09 | NCT07729852 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Alterity Therapeutics | 1 |
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Centre Hospitalier Universitaire de Bordeaux | Bordeaux | France | 1 |
| Hôpital de la Timone | Marseille | France | 1 |
| Hôpital Pierre-Paul Riquet | Toulouse | France | 1 |
| Hôpital Universitaire Pitié Salpêtrière | Paris | France | 4 |